Nanopath Inc.
Cambridge, MA Nanopath Inc.
- UEI
- MURFWBMTD7F7
- CAGE
- 8G6H4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 750 Main St, Cambridge, MA 02139, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Multiplexed assay for point-of-care UTI diagnosis (ID/AMR) - project summary nanopath proposes to develop a… | National Institute of Allergy and Infectious Diseases | $3,878,252 | |
| Sbir phase II: integrated point-of-care system for rapid pathogen identification and characterization -the broader… | National Science Foundation | $1,497,781 | |
| Sbir phase i: integrated point-of-care system for rapid pathogen identification in urinary tract infections | Division of Industrial Innovation | $255,874 |
About Nanopath Inc.
Nanopath Inc. is a woman-owned small business registered to receive federal government awards since December 2019. The company specializes in developing innovative diagnostic technologies for rapid pathogen detection and characterization, with a focus on point-of-care applications. Nanopath's core technology involves proprietary nanosensor-based systems that can identify pathogens and antibiotic resistance markers directly from patient samples within minutes, without the need for traditional culture or nucleic acid amplification methods. Their work primarily targets improving diagnostic workflows for common infections such as urinary tract infections (UTIs), aiming to expedite treatment and combat antibiotic resistance.
Through federal grant awards, Nanopath Inc. has received funding to advance its diagnostic platform for multiple applications. The National Institute of Allergy and Infectious Diseases (NIAID) awarded the company a $996,726 grant to develop a 15-minute point-of-care molecular diagnostic test for UTIs, capable of identifying pathogens and antibiotic resistance markers directly from urine samples. This project aims to expand the detection panel to cover over 95% of UTI-causing organisms and optimize the assay cartridge design. Additionally, the National Science Foundation (NSF) provided a $997,781 cooperative agreement under its Technology, Innovation, and Partnerships program for Nanopath to further develop its integrated point-of-care system for rapid pathogen identification and characterization. This NSF-funded project focuses on nanosensor fabrication, data analysis optimization, and system integration for single-step operation. Nanopath also received a smaller $255,874 NSF grant through the Engineering program to specifically target the development of a rapid pathogen identification system for UTIs. These grant-funded projects demonstrate Nanopath's commitment to advancing diagnostic technologies that can significantly improve patient care and antibiotic stewardship across various infectious disease scenarios.
Quick answers
What is Nanopath Inc.'s UEI?
Nanopath Inc.'s Unique Entity ID (UEI) in SAM.gov is MURFWBMTD7F7.
What is Nanopath Inc.'s CAGE code?
Nanopath Inc.'s CAGE code is 8G6H4.
What is Nanopath Inc.'s primary NAICS code?
Nanopath Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Nanopath Inc. located?
Nanopath Inc.'s physical address in SAM.gov is 750 Main St, Cambridge, MA 02139, USA.
Is Nanopath Inc. registered in SAM.gov?
Yes. Nanopath Inc.'s SAM.gov registration is active through September 9, 2027.
What is Nanopath Inc.'s most recent federal award?
Nanopath Inc.'s most recent federal grant award is Multiplexed assay for point-of-care UTI diagnosis (ID/AMR) - project summary nanopath proposes to develop a… (R44AI181154), from National Institute of Allergy and Infectious Diseases, on March 1, 2024.
On GovTribe
See Nanopath Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors